Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SANUWAVE Health, Inc.SNVW · Entity 7321 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SANUWAVE Health, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.71 · Expires 2031-09-30 | Direct | 11,286 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 11,286 · Balance 11,286 F1: Options were fully vested at the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Options were fully vested at the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 01:07 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 11,286 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0002012756-26-000008 · form4-10022026_091056.xml · derivative · entry 1 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 Underlying: Common Stock · 11,286 shares Expires 2031-09-30 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:12 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 5,524 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0002012756-26-000006 · form4-07022026_080759.xml · derivative · entry 1 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,524 Underlying: Common Stock · 5,524 shares Expires 2031-06-30 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:10 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 3,208 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0002012756-26-000004 · form4-04022026_090458.xml · derivative · entry 1 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,208 Underlying: Common Stock · 3,208 shares Expires 2031-03-31 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 21:35 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,540 | $0.00 Strike: $29.84 | $0.00 |
DisclosureSEC source: 0002012756-26-000002 · form4-01062026_090129.xml · derivative · entry 1 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,540 Underlying: Common Stock · 1,540 shares Expires 2030-12-31 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 21:48 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,342 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0002012756-25-000003 · form4-10022025_091021.xml · derivative · entry 1 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,342 Underlying: Common Stock · 1,342 shares Expires 2030-09-30 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:33 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,574 | $0.00 Strike: $32.86 | $0.00 |
DisclosureSEC source: 0001437749-25-022057 · rdgdoc.xml · derivative · entry 1 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires 2030-06-30 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 20:14 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,761 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001437749-25-011185 · rdgdoc.xml · derivative · entry 1 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,761 Underlying: Common Stock · 1,761 shares Expires 2030-04-03 F1 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| December 31, 2024 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 1,559 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · derivative · entry 11 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,559 Underlying: Common Stock · 1,559 shares Expires 2029-12-31 F5 · derivative.exercise_date: Options were fully vested at the grant date. Read SEC document |
| October 22, 2024 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 41,333 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · derivative · entry 10 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,333 Underlying: Common Stock · 41,333 shares Expires 2034-10-22 F4 · derivative.exercise_date: Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. Read SEC document |
| October 18, 2024 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | Disposition to issuerCommon Stock Purchase Warrant (right to buy) · Derivative | 3,000 | Not disclosed Strike: $25.13 | Not disclosed |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · derivative · entry 9 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2027-08-05 F2 · shares: On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 5,250 shares of common stock pursuant to a letter agreement between the reporting person and the Company. F2 · price: On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 5,250 shares of common stock pursuant to a letter agreement between the reporting person and the Company. Read SEC document |
| October 18, 2024 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | Disposition to issuerCommon Stock Purchase Warrant (right to buy) · Derivative | 3,000 | Not disclosed Strike: $15.00 | Not disclosed |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · derivative · entry 7 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2027-08-05 F2 · shares: On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 5,250 shares of common stock pursuant to a letter agreement between the reporting person and the Company. F2 · price: On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 5,250 shares of common stock pursuant to a letter agreement between the reporting person and the Company. Read SEC document |
| October 18, 2024 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantCommon Stock | 2,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · nonDerivative · entry 3 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,700 F2 · shares: On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 5,250 shares of common stock pursuant to a letter agreement between the reporting person and the Company. F2 · price: On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 5,250 shares of common stock pursuant to a letter agreement between the reporting person and the Company. Read SEC document |
| October 18, 2024 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantCommon Stock | 2,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · nonDerivative · entry 2 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,150 F2 · shares: On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 5,250 shares of common stock pursuant to a letter agreement between the reporting person and the Company. F2 · price: On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 5,250 shares of common stock pursuant to a letter agreement between the reporting person and the Company. Read SEC document |
| August 05, 2023 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | ConversionFuture Advance Convertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $15.00 | $51,750.00 |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · derivative · entry 5 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,450 shares Expires 2023-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · reported_value: Pursuant to the terms of the Future Advance Convertible Promissory Note issued by SANUWAVE Health, Inc. (the "Company") on August 5, 2022, all principal and accrued interest due as of the maturity date, August 5, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share. Read SEC document |
| August 05, 2023 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | ConversionCommon Stock | 3,450 | $15.00 | $51,750.00 |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · nonDerivative · entry 1 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the terms of the Future Advance Convertible Promissory Note issued by SANUWAVE Health, Inc. (the "Company") on August 5, 2022, all principal and accrued interest due as of the maturity date, August 5, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share. Read SEC document |
| August 05, 2022 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantCommon Stock Purchase Warrant (right to buy) · Derivative | 3,000 | Not disclosed Strike: $25.13 | Not disclosed |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · derivative · entry 8 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2027-08-05 F3 · price: On August 5, 2022, in exchange for $45,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $45,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 3,000 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 3,000 shares of common stock at an exercise price of approximately $25.13 per share). Read SEC document |
| August 05, 2022 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantCommon Stock Purchase Warrant (right to buy) · Derivative | 3,000 | Not disclosed Strike: $15.00 | Not disclosed |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · derivative · entry 6 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2027-08-05 F3 · price: On August 5, 2022, in exchange for $45,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $45,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 3,000 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 3,000 shares of common stock at an exercise price of approximately $25.13 per share). Read SEC document |
| August 05, 2022 Filed Mar 4, 2025 21:13 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantFuture Advance Convertible Promissory Note · Derivative | Not disclosed | $45,000.00 Strike: $15.00 | $45,000.00 |
DisclosureSEC source: 0001437749-25-006104 · rdgdoc.xml · derivative · entry 4 Tyler James · CIK 0002012756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 3,000 shares Expires 2023-08-05 F3 · reported_value: On August 5, 2022, in exchange for $45,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $45,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 3,000 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 3,000 shares of common stock at an exercise price of approximately $25.13 per share). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.